| abstract |
The present invention relates to the field of biotechnology or genetic engineering. Specifically, the invention relates to the field of gene expression. More specifically, the present invention provides novel ecdysone receptor / chimeric retinoid X receptor-based inducible gene expression systems and gene therapy, large-scale production of proteins and antibodies, cell-based high-throughput screening assays Methods of modulating gene expression in host cells for applications such as functional genomics and modulation of properties in transgenic organisms. |